Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240452 in CMAJ.
FDA Eases Fears of Major Drug Shortages After Tornado Damages Pfizer Facility
Last week’s tornado in North Carolina should not cause too much of an immediate disruption in the supply of drugs manufactured at a Rocky Mount,
July 25, 2023